logo-loader
Xphyto Therapeutics Corp.

Xphyto Therapeutics shares begin trading on the Frankfurt Stock Exchange

The company is developing analytical testing, processing, and formulation capability in Canada and research, cultivation, extraction, import, distribution, and manufacturing in Germany

Xphyto Therapeutics Corp. - Xphyto Therapeutics shares begin trading on the Frankfurt Stock Exchange
XPhyto is now dual-listed in both Canada and Germany

XPhyto Therapeutics Corp (CSE:XPHY), the science-focused cannabis company, announced Tuesday that its shares have begun trading on the Frankfurt Stock Exchange under the symbol ‘4XT.’

The Vancouver-based company is developing analytical testing, processing, and formulation capability in Canada and research, cultivation, extraction, import, distribution, and manufacturing in Germany.

It has 100% ownership of the German cannabis company Bunker Pflanzenextrakte GmbH, operating from a decommissioned German Air Force command center and nuclear bunker near Munich, which is the largest cannabis laboratory in Germany.

READ: XPhyto Therapeutics is taking a scientific approach to medical cannabis with a unique business model

"Given XPhyto's German cannabis licence and its commitment to building import and distribution capability in the country, a Frankfurt listing was a logical choice," said Hugh Rogers, XPhyto’s CEO.

"We are excited to help facilitate the opportunity for German investors to participate in their own emerging cannabis industry,” Rogers said in a statement. “XPhyto considers itself one of the only German focused cannabis companies in the world."

The German Federal Institute for Drugs and Medical Devices (BfArM) recently granted Bunker Pflanzenextrakte a cannabis cultivation and extraction licence for scientific purposes.

Shares of XPhyto were up 5.8% at C$1.28 on Tuesday midday on the Canadian Securities Exchange.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Xphyto Therapeutics Corp.

Price: $1.30

Market: CSE
Market Cap: $61.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xphyto Therapeutics Corp. named herein, including the promotion by the Company of Xphyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: XPhyto Therapeutics shares begin trading on the CSE

XPhyto Therapeutics Corp (CSE:XPHY) CEO Hugh Rogers tells Proactive Investors the Vancouver-based company has begun trading on the Canadian Securities Exchange under the ticker symbol "XPHY". Rogers says XPhyto's German cannabis cultivation and extraction licence positions the...

2 weeks, 4 days ago

2 min read